Ladenburg Thalmann Financial Services’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
Other funds holding SNOA
BA
RE
Ladenburg Thalmann Financial Services's SNOA Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services held its Sonoma Pharmaceuticals (SNOA) position steady in Q4 2019 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5228.
Ladenburg Thalmann Financial Services first reported a position in SNOA in Q2 2013 and has held it in 27 quarters since. The position peaked at $21K in Q4 2017. 13 funds tracked by Wall St. Rank hold SNOA as of Q4 2019.
- Ladenburg Thalmann Financial Services held 8 shares of Sonoma Pharmaceuticals worth $1K as of Q4 2019.
- Ladenburg Thalmann Financial Services left its Sonoma Pharmaceuticals share count unchanged in Q4 2019.
- Sonoma Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5228 holding.
- Ladenburg Thalmann Financial Services first reported a position in Sonoma Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
- Ladenburg Thalmann Financial Services's Sonoma Pharmaceuticals position peaked at $21K in Q4 2017.
- 13 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.